SCHEMBL5846796

SCHEMBL5846796

CC(C)c1oc(-c2ccccc2Cl)nc1CCC(=O)c1ccccc1CCl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.47
PPARD Q03181 4/20 0.47
PPARA Q07869 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.41
TP53 P04637 2/20 0.41
POLB P06746 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
PTBP1 P26599 1/20 0.41
MAPT P10636 3/20 0.40
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
TSHR P16473 1/20 0.39
THRB P10828 1/20 0.37
IKBKB O14920 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36
HPGD P15428 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5846370 0.94 PPARD (0.46) PPARGPPARDPPARASMN1; SMN2TP53
SCHEMBL5845152 0.85 PPARD (0.45) PPARGPPARDPPARASMN1; SMN2TP53
SCHEMBL5846793 0.84 PPARD (0.47) PPARGPPARDPPARASMN1; SMN2TP53
SCHEMBL376890 0.82 PPARG (0.49) PPARGPPARDPPARASMN1; SMN2TP53
SCHEMBL7101627 0.79 PPARG (0.51) PPARGPPARDPPARASMN1; SMN2TP53
SCHEMBL5845384 0.78 PPARD (0.47) PPARGPPARDPPARASMN1; SMN2TP53
SCHEMBL5846365 0.78 PPARD (0.46) PPARGPPARDPPARASMN1; SMN2TP53
SCHEMBL5845568 0.78 PPARG (0.51) PPARGPPARDPPARASMN1; SMN2TP53
SCHEMBL5845540 0.77 PPARD (0.45) PPARGPPARDPPARASMN1; SMN2TP53
SCHEMBL5846647 0.76 PPARD (0.52) PPARGPPARDPPARASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078422-B2 Activator for peroxisome proliferator-activated receptor NIPPON CHEMIPHAR CO., LTD. (JP) 2006-07-18 US disclosed
US-20040152744-A1 Activator for peroxisome proliferator- activated receptor NIPPON CHEMIPHAR CO., LTD. (JP) 2004-08-05 US disclosed
EP-1371650-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO., LTD. (JP) 2003-12-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152744-A1 Activator for peroxisome proliferator- activated receptor PPARA, PPARG, PPARD PPARG 2/4885PPARD 3/4885PPARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.